After 5 days of treatment with IL-2, the patient developed a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia.
toxic epidermal necrolysis
IL-2
hemorrhagic lesion
IL-2
pancytopenia
IL-2